BIOMERICA INC

BMRA
交易所
Nasdaq
產業
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000073290

內部人交易

每一列是一份 Form 4 申報裡同一種交易的合計。預設只顯示公開市場買進(P)與賣出(S);要看公司授予、行使選擇權等其他代碼,請調整篩選條件。

內部人交易
申報時間(美東)交易日內部人交易股數均價金額交易後持股持股變化申報
2026/8/2717:27 ET2026/8/20Gary M. Huff董事P買進Common stock+3.13 萬$1.60+$5 萬5.13 萬+156.3%SEC
2026/8/2717:26 ET2026/8/26MOATAZEDI DAVID董事P買進Common stock+1 萬$1.60+$1.6 萬4.06 萬+32.7%SEC
2026/8/2717:26 ET2026/8/26Chin Eric董事P買進Common stock+6,250$1.60+$1 萬3.88 萬+19.2%SEC
2026/8/2717:24 ET2026/8/26BARBIERI ALLENExecutive Vice ChairmanP買進Common stock+2 萬$1.60+$3.2 萬7.35 萬+37.4%SEC
2026/8/2717:23 ET2026/8/26Irani Zackary S.執行長P買進Common stock+3.13 萬$1.60+$5 萬24.26 萬+14.8%SEC
2023/5/262023/5/24–5/25Irani Zackary S.執行長P買進Common Stock+700$1.5929+$1,115102.06 萬+0.1%SEC
2023/5/122023/5/12Irani Zackary S.執行長P買進Common Stock+1,700$1.17+$1,989101.99 萬+0.2%SEC
2023/5/122023/5/10Irani Zackary S.執行長P買進Common Stock+500$1.27+$635101.82 萬0.0%SEC
2023/5/102023/5/9Irani Zackary S.執行長P買進Common Stock+300$1.39+$417101.77 萬0.0%SEC
2023/5/52023/5/4Irani Zackary S.執行長P買進Common Stock+1,000$1.36+$1,360101.74 萬+0.1%SEC
2023/5/12023/4/27–4/28Irani Zackary S.執行長P買進Common Stock+4,400$1.3223+$5,818101.74 萬+0.4%SEC
2023/4/272023/4/26Irani Zackary S.執行長P買進Common Stock+7,000$1.26+$8,820101.3 萬+0.7%SEC
2023/1/312023/1/27BARBIERI ALLENExecutive Vice ChairmanP買進Common Stock+1,538$2.94+$4,521.7210.13 萬+1.5%SEC
2023/1/302023/1/26Coste Catherine董事、其他:Audit Committee ChairpersonP買進Common Stock+2,190$2.96+$6,482.44.38 萬+5.3%SEC
2023/1/262023/1/25Irani Zackary S.執行長P買進Common Stock+1,800$2.85+$5,130100.6 萬+0.2%SEC
2023/1/252023/1/24Irani Zackary S.執行長P買進Common Stock+2,000$2.81+$5,620100.42 萬+0.2%SEC